Innate Pharma S.A. ADS (IPHA)

EARNINGS ANALYTICS
search

Earnings reactions

How IPHA moved on each past earnings report.

Up Down

Earnings Impact

Innate Pharma S.A. ADS (IPHA) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.

Historical Earnings Statistics

Innate Pharma S.A. ADS (IPHA) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.

event

Earnings Count

0

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.00%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 2 →
2
Funds holding
$82592
Total value held
Buying
1 added · 0 reduced
Morgan Stanley
$80084 Held
Ubs Group Ag
$2508 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
6-K 20260902 open_in_new SEC.gov
6-K 20260819 open_in_new SEC.gov
6-K 20260814 open_in_new SEC.gov
6-K 20260810 open_in_new SEC.gov
6-K 20260723 open_in_new SEC.gov
6-K 20260721 open_in_new SEC.gov
SCHEDULE 13G/A 20260622 open_in_new SEC.gov
6-K 20260522 open_in_new SEC.gov
6-K 20260519 open_in_new SEC.gov
6-K 20260513 open_in_new SEC.gov